NCT05251389View on ClinicalTrials.gov

FMT to Convert Response to Immunotherapy

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Melanoma Stage IIIMelanoma Stage IV
Interventions
OTHER

Fecal microbiota transplantation

Fecal microbiota transplantation of an ICI responding or Fecal microbiota transplantation from an ICI non-responding donor, in combination with ICI.

Trial Locations (1)

1066CX

RECRUITING

Antoni van Leeuwenhoek, Amsterdam

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER